Safety and efficacy of the fixed-dose combination regimen of MK-3682/grazoprevir/ruzasvir in cirrhotic or non-cirrhotic patients with chronic HCV GT1 infection who previously failed a direct-acting antiviral regimen (C-SURGE)

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2017, Vol.66 (1), p.S85-S85
Main Authors: Wedemeyer, H, Wyles, D, Reddy, R, Luetkemeyer, A, Jacobson, I, Vierling, J.M, Gordon, S, Nahass, R, Zeuzem, S, Wahl, J, Barr, E, Nguyen, B.-Y.T, Robertson, M, Joeng, H.-K, Liu, H, Jumes, P, Dutko, F, Martin, E
Format: Article
Language:English
Subjects:
Gastroenterology and Hepatology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
DOI:10.1016/S0168-8278(17)30435-X